Dyne Therapeutics, Inc. (DYN)
16.62
-0.54
(-3.18%)
USD |
NASDAQ |
Nov 16, 14:07
Dyne Therapeutics Price to Book Value : 3.343 for Nov. 16, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 3.453 |
| November 12, 2026 | 3.423 |
| November 11, 2026 | 3.620 |
| November 10, 2026 | 3.606 |
| November 09, 2026 | 3.747 |
| November 06, 2026 | 3.636 |
| November 05, 2026 | 3.493 |
| November 04, 2026 | 3.731 |
| November 03, 2026 | 3.632 |
| November 02, 2026 | 3.481 |
| October 30, 2026 | 3.358 |
| October 29, 2026 | 3.429 |
| October 28, 2026 | 3.417 |
| October 27, 2026 | 3.409 |
| October 26, 2026 | 3.163 |
| October 23, 2026 | 3.143 |
| October 22, 2026 | 3.173 |
| October 21, 2026 | 3.234 |
| October 20, 2026 | 3.274 |
| October 19, 2026 | 3.065 |
| October 16, 2026 | 2.868 |
| October 15, 2026 | 3.077 |
| October 14, 2026 | 3.026 |
| October 13, 2026 | 3.079 |
| October 12, 2026 | 3.212 |
| Date | Value |
|---|---|
| October 09, 2026 | 3.348 |
| October 08, 2026 | 3.294 |
| October 07, 2026 | 3.214 |
| October 06, 2026 | 3.099 |
| October 05, 2026 | 3.107 |
| October 02, 2026 | 3.059 |
| October 01, 2026 | 3.183 |
| September 30, 2026 | 3.242 |
| September 29, 2026 | 3.825 |
| September 28, 2026 | 3.855 |
| September 25, 2026 | 3.782 |
| September 24, 2026 | 3.896 |
| September 23, 2026 | 3.829 |
| September 22, 2026 | 4.044 |
| September 21, 2026 | 4.039 |
| September 18, 2026 | 4.037 |
| September 17, 2026 | 4.261 |
| September 16, 2026 | 4.083 |
| September 15, 2026 | 4.224 |
| September 14, 2026 | 4.370 |
| September 11, 2026 | 4.297 |
| September 10, 2026 | 4.346 |
| September 09, 2026 | 4.528 |
| September 08, 2026 | 4.792 |
| September 04, 2026 | 5.729 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.57 |
| Anika Therapeutics, Inc. | 1.266 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.476 |
Price to Book Value Related Metrics
| Price | 16.62 |
| Earnings Yield | -21.88% |
| Market Cap | 3.112B |